High loading efficiency and sustained release of siRNA encapsulated in PLGA nanoparticles: quality by design optimization and characterization.

Poly(DL-lactide-co-glycolide acid) (PLGA) is an attractive polymer for delivery of biopharmaceuticals owing to its biocompatibility, biodegradability and outstanding controlled release characteristics. The purpose of this study was to understand and define optimal parameters for preparation of small interfering RNA (siRNA)-loaded PLGA nanoparticles by the double emulsion solvent evaporation method and characterize their properties. The experiments were performed according to a 2(5-1) fractional factorial design based on five independent variables: The volume ratio between the inner water phase and the oil phase, the PLGA concentration, the sonication time, the siRNA load and the amount of acetylated bovine serum albumin (Ac-BSA) in the inner water phase added to stabilize the primary emulsion. The effects on the siRNA encapsulation efficiency and the particle size were investigated. The most important factors for obtaining an encapsulation efficiency as high as 70% were the PLGA concentration and the volume ratio whereas the size was mainly affected by the PLGA concentration. The viscosity of the oil phase was increased at high PLGA concentration, which explains the improved encapsulation by stabilization of the primary emulsion and reduction of siRNA leakage to the outer water phase. Addition of Ac-BSA increased the encapsulation efficiency at low PLGA concentrations. The PLGA matrix protected siRNA against nuclease degradation, provided a burst release of surface-localized siRNA followed by a triphasic sustained release for two months. These results enable careful understanding and definition of optimal process parameters for preparation of PLGA nanoparticles encapsulating high amounts of siRNA with immediate and long-term sustained release properties.

[1]  M. Alonso,et al.  Protein encapsulation and release from poly(lactide-co-glycolide) microspheres: effect of the protein and polymer properties and of the co-encapsulation of surfactants. , 1998, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[2]  C. Madden,et al.  Characterization of antigens adsorbed to anionic PLG microparticles by XPS and TOF-SIMS. , 2008, Journal of pharmaceutical sciences.

[3]  Shubiao Zhang,et al.  Toxicity of cationic lipids and cationic polymers in gene delivery. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[4]  Michael J. Campolongo,et al.  Drug delivery: Old polymer learns new tracts. , 2009, Nature materials.

[5]  H. Sah,et al.  Biodegradable microcapsules prepared by a w/o/w technique: effects of shear force to make a primary w/o emulsion on their morphology and protein release. , 1995, Journal of microencapsulation.

[6]  W. Saltzman,et al.  High loading efficiency and tunable release of plasmid DNA encapsulated in submicron particles fabricated from PLGA conjugated with poly-L-lysine. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[7]  R Fisher,et al.  Design of Experiments , 1936 .

[8]  H. Okada,et al.  Controlled Release of LHRH Agonist, Leuprolide Acetate, from Microcapsules: Serum Drug Level Profiles and Pharmacological Effects in Animals , 1989, The Journal of pharmacy and pharmacology.

[9]  R. Levy,et al.  Sustained delivery and expression of DNA encapsulated in polymeric nanoparticles , 2000, Gene Therapy.

[10]  H. Okada,et al.  One- and three-month release injectable microspheres of the LH-RH superagonist leuprorelin acetate. , 1997, Advanced drug delivery reviews.

[11]  E. Allémann,et al.  Poly(D,L-lactide-co-glycolide) protein-loaded nanoparticles prepared by the double emulsion method—processing and formulation issues for enhanced entrapment efficiency , 2005, Journal of microencapsulation.

[12]  J. Xu,et al.  Effect of WOW process parameters on morphology and burst release of FITC-dextran loaded PLGA microspheres. , 2007, International journal of pharmaceutics.

[13]  D. Castner,et al.  Quantitative X-ray photoelectron spectroscopy and time-of-flight secondary ion mass spectrometry characterization of the components in DNA. , 2004, Analytical chemistry.

[14]  J. Resau,et al.  Characterization and morphological analysis of protein-loaded poly(lactide-co-glycolide) microparticles prepared by water-in-oil-in-water emulsion technique , 1994 .

[15]  M S Wagner,et al.  Characterization of adsorbed protein films by time of flight secondary ion mass spectrometry. , 2001, Journal of biomedical materials research.

[16]  D. Castner,et al.  Time-of-flight secondary ion mass spectrometry: techniques and applications for the characterization of biomaterial surfaces. , 2003, Biomaterials.

[17]  Y. Kawashima,et al.  Establishing chitosan coated PLGA nanosphere platform loaded with wide variety of nucleic acid by complexation with cationic compound for gene delivery. , 2008, International journal of pharmaceutics.

[18]  Tejraj M Aminabhavi,et al.  Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[19]  W. Mark Saltzman,et al.  Intravaginal gene silencing using biodegradable polymer nanoparticles densely loaded with small-interfering RNA , 2009, Nature materials.

[20]  J. Feijen,et al.  The preparation of monodisperse biodegradable polyester nanoparticles with a controlled size. , 2003, Journal of biomedical materials research. Part B, Applied biomaterials.

[21]  Wim E Hennink,et al.  Biodegradable polymers as non-viral carriers for plasmid DNA delivery. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[22]  Hanne Mørck Nielsen,et al.  Preparation and characterization of poly(DL-lactide-co-glycolide) nanoparticles for siRNA delivery. , 2010, International journal of pharmaceutics.

[23]  M. Alexander,et al.  Extracting information on the surface monomer unit distribution of PLGA by ToF‐SIMS , 2008 .

[24]  Scott D. Putney,et al.  Improving protein therapeutics with sustained-release formulations , 1998, Nature Biotechnology.

[25]  Rajesh Singh,et al.  Nanoparticle-based targeted drug delivery. , 2009, Experimental and molecular pathology.

[26]  H. M. Nielsen,et al.  Polymeric nanocarriers for siRNA delivery: Challenges and future prospects , 2008 .

[27]  A. Ludwig,et al.  Biocompatible stabilizers in the preparation of PLGA nanoparticles: a factorial design study. , 2002, International journal of pharmaceutics.

[28]  U. Bakowsky,et al.  Preparation and characterization of cationic PLGA nanospheres as DNA carriers. , 2004, Biomaterials.

[29]  H. M. Nielsen,et al.  Spray drying of siRNA-containing PLGA nanoparticles intended for inhalation , 2009, Journal of Controlled Release.

[30]  D. Lipinsky,et al.  DNA sequencing with ToF‐SIMS , 2002 .

[31]  Rajiv Kumar,et al.  Optimizing drug delivery systems using systematic "design of experiments." Part I: fundamental aspects. , 2005, Critical reviews in therapeutic drug carrier systems.

[32]  Bhupinder Singh,et al.  Optimizing drug delivery systems using systematic "design of experiments." Part II: retrospect and prospects. , 2005, Critical reviews in therapeutic drug carrier systems.

[33]  Jayanth Panyam,et al.  Polymeric nanoparticles for siRNA delivery and gene silencing. , 2009, International journal of pharmaceutics.